Dr. Timothy D. Moore
Claim this profileThe Mark H Zangmeister Center
Expert in Cancer
Expert in Lung Cancer
126 reported clinical trials
208 drugs studied
About Timothy D. Moore
Education:
- Earned a Medical degree (MD) from the University of Pittsburgh School of Medicine.
- Completed an Internship at the University of Cincinnati School of Medicine.
- Served as Chief Resident during his Residency at Mercy Hospital in Pittsburgh.
- Undertook a Fellowship in Hematology/Oncology at The Ohio State University School of Medicine.
Experience:
- Held Senior Investigator positions at the National Cancer Institute, focusing on the Cancer Therapy Evaluation Program.
- Served as an Attending physician at NCI-Navy Medical Oncology Services, Bethesda National Naval Hospital.
- Co-Medical Director for Palliative Care at The Zangmeister Cancer Center.
- Board certified in General Internal Medicine, Hematology, Medical Oncology, and Hospice & Palliative Care Medicine.
Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage I
2Lung Cancer
Global LeaderStage IV
Stage III
Stage II
Affiliated Hospitals
Clinical Trials Timothy D. Moore is currently running
Lomustine + Standard Therapy
for Glioblastoma
This phase III trial compares the effect of adding lomustine to temozolomide and radiation therapy versus temozolomide and radiation therapy alone in shrinking or stabilizing newly diagnosed MGMT methylated glioblastoma. Chemotherapy drugs, such as lomustine and temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Radiation therapy uses high energy photons to kill tumor cells and shrink tumors. Adding lomustine to usual treatment of temozolomide and radiation therapy may help shrink and stabilize glioblastoma.
Recruiting2 awards Phase 34 criteria
Symptom Monitoring
for Young Women on Hormone Therapy
This phase III trial compares the effect of active symptom monitoring and patient education to patient education alone in helping young women with stage I-III breast cancer stay on their hormone therapy medicines. The patient education tool contains interactive weblinks which provide patients with education material about breast cancer and side effects of therapy. Symptom monitoring is a weblink via email or text message with questions asking about symptoms. Hormone therapy for breast cancer can cause side effects, and may cause some women to stop treatment early. Asking about symptoms more often may help women keep taking hormone therapy medicines.
Recruiting1 award N/A13 criteria
More about Timothy D. Moore
Clinical Trial Related4 years of experience running clinical trials · Led 126 trials as a Principal Investigator · 61 Active Clinical TrialsTreatments Timothy D. Moore has experience with
- Carboplatin
- Paclitaxel
- Pembrolizumab
- Nivolumab
- Cisplatin
- Atezolizumab
Breakdown of trials Timothy D. Moore has run
Cancer
Lung Cancer
Breast Cancer
Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Timothy D. Moore specialize in?
Timothy D. Moore focuses on Cancer and Lung Cancer. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage III.
Is Timothy D. Moore currently recruiting for clinical trials?
Yes, Timothy D. Moore is currently recruiting for 57 clinical trials in Columbus Ohio. If you're interested in participating, you should apply.
Are there any treatments that Timothy D. Moore has studied deeply?
Yes, Timothy D. Moore has studied treatments such as Carboplatin, Paclitaxel, Pembrolizumab.
What is the best way to schedule an appointment with Timothy D. Moore?
Apply for one of the trials that Timothy D. Moore is conducting.
What is the office address of Timothy D. Moore?
The office of Timothy D. Moore is located at: The Mark H Zangmeister Center, Columbus, Ohio 43219 United States. This is the address for their practice at the The Mark H Zangmeister Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.